Encompass Health Corporation $EHC Shares Bought by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 7.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 25,898 shares of the company’s stock after purchasing an additional 1,815 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Encompass Health were worth $3,176,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Invesco Ltd. increased its position in Encompass Health by 5.1% during the 1st quarter. Invesco Ltd. now owns 5,818,783 shares of the company’s stock valued at $589,326,000 after buying an additional 282,532 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its stake in shares of Encompass Health by 25.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock worth $210,756,000 after acquiring an additional 424,691 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Encompass Health by 5.3% during the first quarter. Dimensional Fund Advisors LP now owns 1,871,581 shares of the company’s stock valued at $189,549,000 after acquiring an additional 93,992 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of Encompass Health by 13.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,822,376 shares of the company’s stock valued at $184,571,000 after purchasing an additional 211,707 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in Encompass Health by 0.5% in the 2nd quarter. Geode Capital Management LLC now owns 1,773,547 shares of the company’s stock worth $217,526,000 after purchasing an additional 8,765 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Price Performance

Shares of EHC opened at $111.73 on Thursday. The business’s 50-day moving average is $121.85 and its two-hundred day moving average is $119.60. The company has a market capitalization of $11.24 billion, a P/E ratio of 21.12, a P/E/G ratio of 2.20 and a beta of 0.91. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Friday, January 2nd. Encompass Health’s payout ratio is currently 14.37%.

Insider Transactions at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the firm’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president owned 18,846 shares in the company, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 2.10% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on EHC shares. UBS Group upped their price target on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Truist Financial raised their target price on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research note on Thursday, August 14th. Zacks Research raised Encompass Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 21st. Barclays increased their price objective on Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Finally, Wall Street Zen downgraded Encompass Health from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Three equities research analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $142.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.